Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 173

    1.

    Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin.

    Hubbard RC, Brantly ML, Sellers SE, Mitchell ME, Crystal RG.

    Ann Intern Med. 1989 Aug 1;111(3):206-12.PMID: 2787611 [PubMed - indexed for MEDLINE]Related articles

    2.

    Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.

    Hubbard RC, McElvaney NG, Sellers SE, Healy JT, Czerski DB, Crystal RG.

    J Clin Invest. 1989 Oct;84(4):1349-54.PMID: 2794066 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route.

    Hubbard RC, Crystal RG.

    Lung. 1990;168 Suppl:565-78.PMID: 2117165 [PubMed - indexed for MEDLINE]Related articles

    4.

    Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.

    Wewers MD, Casolaro MA, Sellers SE, Swayze SC, McPhaul KM, Wittes JT, Crystal RG.

    N Engl J Med. 1987 Apr 23;316(17):1055-62.PMID: 3494198 [PubMed - indexed for MEDLINE]Related articles

    5.

    Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.

    Hubbard RC, Crystal RG.

    Am J Med. 1988 Jun 24;84(6A):52-62. Review.PMID: 3289387 [PubMed - indexed for MEDLINE]Related articles

    6.

    Fate of aerosolized recombinant DNA-produced alpha 1-antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance.

    Hubbard RC, Casolaro MA, Mitchell M, Sellers SE, Arabia F, Matthay MA, Crystal RG.

    Proc Natl Acad Sci U S A. 1989 Jan;86(2):680-4.PMID: 2783491 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase.

    Ogushi F, Hubbard RC, Fells GA, Casolaro MA, Curiel DT, Brantly ML, Crystal RG.

    Am Rev Respir Dis. 1988 Feb;137(2):364-70.PMID: 3257660 [PubMed - indexed for MEDLINE]Related articles

    8.

    Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep.

    Smith RM, Traber LD, Traber DL, Spragg RG.

    J Clin Invest. 1989 Oct;84(4):1145-54.PMID: 2794051 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency.

    Hubbard RC, Sellers S, Czerski D, Stephens L, Crystal RG.

    JAMA. 1988 Sep 2;260(9):1259-64.PMID: 3261353 [PubMed - indexed for MEDLINE]Related articles

    10.

    Augmentation therapy of alpha 1-antitrypsin deficiency.

    Hubbard RC, Crystal RG.

    Eur Respir J Suppl. 1990 Mar;9:44s-52s.PMID: 2340051 [PubMed - indexed for MEDLINE]Related articles

    11.

    Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.

    Ogushi F, Fells GA, Hubbard RC, Straus SD, Crystal RG.

    J Clin Invest. 1987 Nov;80(5):1366-74.PMID: 3500183 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.

    McElvaney NG, Hubbard RC, Birrer P, Chernick MS, Caplan DB, Frank MM, Crystal RG.

    Lancet. 1991 Feb 16;337(8738):392-4.PMID: 1671425 [PubMed - indexed for MEDLINE]Related articles

    14.

    Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase.

    Ogushi F, Hubbard RC, Vogelmeier C, Fells GA, Crystal RG.

    J Clin Invest. 1991 Mar;87(3):1060-5.PMID: 1999486 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.

    Hubbard RC, Fells G, Gadek J, Pacholok S, Humes J, Crystal RG.

    J Clin Invest. 1991 Sep;88(3):891-7.PMID: 1653278 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.

    Gadek JE, Fells GA, Zimmerman RL, Rennard SI, Crystal RG.

    J Clin Invest. 1981 Oct;68(4):889-98.PMID: 6169740 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium.

    Vogelmeier C, Buhl R, Hoyt RF, Wilson E, Fells GA, Hubbard RC, Schnebli HP, Thompson RC, Crystal RG.

    J Appl Physiol. 1990 Nov;69(5):1843-8.PMID: 2272977 [PubMed - indexed for MEDLINE]Related articles

    18.

    Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid.

    Gillissen A, Birrer P, McElvaney NG, Buhl R, Vogelmeier C, Hoyt RF Jr, Hubbard RC, Crystal RG.

    J Appl Physiol. 1993 Aug;75(2):825-32.PMID: 7901193 [PubMed - indexed for MEDLINE]Related articles

    19.

    The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency.

    Martorana PA, Brand T, Gardi C, van Even P, de Santi MM, Calzoni P, Marcolongo P, Lungarella G.

    Lab Invest. 1993 Feb;68(2):233-41.PMID: 8441253 [PubMed - indexed for MEDLINE]Related articles

    20.

    Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.

    Hubbard RC, Ogushi F, Fells GA, Cantin AM, Jallat S, Courtney M, Crystal RG.

    J Clin Invest. 1987 Nov;80(5):1289-95.PMID: 2824559 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data